Related Experiment Video
Updated: Jul 9, 2026
Place and Response Learning in the Open-field Tower Maze
Published on: October 28, 2015
Effects of continuous versus cyclical oral contraception: a randomized controlled trial
Richard S Legro1, Jaimey G Pauli, Allen R Kunselman
1Department of Obstetrics and Gynecology, Pennsylvania State University College of Medicine, M.S. Hershey Medical Center, 500 University Drive, H103, Hershey, Pennsylvania 17033, USA. RSL1@PSU.EDU.
Context:
Continuous oral contraception may better suppress the ovary and endometrium, lending itself to the treatment of other medical conditions.
Objective:
Our objective was to determine the effects of continuous vs. cyclical oral contraception.
Design:
This was a randomized double-blind trial.
Setting:
This trial was performed at an academic medical center in Pennsylvania.
Patients:
A total of 62 healthy women with regular menses were included in the study.
Intervention:
Cyclical oral contraception (21-d active/7-d placebo given for six consecutive 28-d cycles) vs. continuous (168-d active pill) therapy using a monophasic pill (20 microg ethinyl estradiol and 1 mg norethindrone acetate) was examined.
Main Outcome Measures:
The primary outcome was vaginal bleeding, and secondary outcomes included hormonal, pelvic ultrasound, quality of life, and safety measures.
Results:
There was no statistically significant difference in the number of total bleeding days between groups, but moderate/heavy bleeding was significantly greater with the cyclical regimen [mean 11.0 d (sd 8.5) vs. continuous 5.2 d (sd 6.8); P = 0.005], with both groups decreasing over time. Endogenous serum and urinary estrogens measured over six cycles were significantly lower (P = 0.02 and 0.04, respectively) in the continuous group than the cyclical group. Women in the continuous group also had a smaller ovarian volume and lead follicle size over the course of the trial by serial ultrasound examinations. The Moos Menstrual Distress Questionnaire showed that women on continuous therapy had less associated menstrual pain (P = 0.01) and favorable improvements in behavior (P = 0.04) during the premenstrual period.
Conclusions:
Continuous oral contraception does not result in a reduction of bleeding days over a 168-d period of observation but provides greater suppression of the ovary and endometrium. These effects are associated with improved patient symptomatology.
Related Concept Videos
01:26Oral Drug Delivery Systems: Continuous-Release Systems
01:22Birth Control Methods
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:21Intrauterine Drug Delivery Systems
01:16Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.